Article

Oral sulforaphane increases Phase II antioxidant enzymes in the human upper airway

The Hart and Louis Laboratory, Clinical Immunology and Allergy, Department of Medicine, UCLA David Geffen School of Medicine, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA
Clinical Immunology (Impact Factor: 3.99). 03/2009; DOI: 10.1016/j.clim.2008.10.007

ABSTRACT BackgroundCellular oxidative stress is an important factor in asthma and is thought to be the principle mechanism by which oxidant pollutants such as ozone and particulates mediate their pro-inflammatory effects. Endogenous Phase II enzymes abrogate oxidative stress through the scavenging of reactive oxygen species and metabolism of reactive chemicals.ObjectiveWe conducted a placebo-controlled dose escalation trial to investigate the in vivo effects of sulforaphane, a naturally occurring potent inducer of Phase II enzymes, on the expression of glutathione-s-transferase M1 (GSTM1), glutathione-s-transferase P1 (GSTP1), NADPH quinone oxidoreductase (NQO1), and hemoxygenase-1 (HO-1) in the upper airway of human subjects.MethodsStudy subjects consumed oral sulforaphane doses contained in a standardized broccoli sprout homogenate (BSH). RNA expression for selected Phase II enzymes was measured in nasal lavage cells by RT-PCR before and after sulforaphane dosing.ResultsAll subjects tolerated oral sulforaphane dosing without significant adverse events. Increased Phase II enzyme expression in nasal lavage cells occurred in a dose-dependent manner with maximal enzyme induction observed at the highest dose of 200 g broccoli sprouts prepared as BSH. Significant increases were seen in all sentinel Phase II enzymes RNA expression compared to baseline. Phase II enzyme induction was not seen with ingestion of non-sulforaphane containing alfalfa sprouts.ConclusionOral sulforaphane safely and effectively induces mucosal Phase II enzyme expression in the upper airway of human subjects. This study demonstrates the potential of antioxidant Phase II enzymes induction in the human airway as a strategy to reduce the inflammatory effects of oxidative stress.Clinical implicationsThis study demonstrates the potential of enhancement of Phase II enzyme expression as a novel therapeutic strategy for oxidant induced airway disease.Capsule summaryA placebo-controlled dose escalation trial demonstrated that naturally occurring sulforaphane from broccoli sprouts can induce a potent increase in antioxidant Phase II enzymes in airway cells.

0 Followers
 · 
77 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This study was performed to evaluate the nutritional effect of cauliflower and broccoli against development vascular histological alterations and related changes in biochemical parameters induced by feeding of rats on animal fat diet. The 24 adult male rats (105±5g) were randomly divided into 4 groups, negative control, animal fat diet (positive control), animal fat diet supplemented either with 5% fiber of cauliflower or broccoli for third and fourth group respectively. Estimation of serum glucose, lipid profile, liver and kidney function were performed and histopathological and immunohistochemical studies on blood vessels, liver and kidney were carried out. Results revealed that cauliflower improves the lipid profile than broccoli. Both plants significantly lowering of serum total lipid, total cholesterol, HDL-C, LDL-C and VLDL-C compared with positive control, improvement of liver and kidney function were achieved in the cauliflower and broccoli supplemented dietary groups. Histopathological examination showed alleviation of vascular histopathological alterations that were observed in animal fat diet fed group including focal intimal thickening and vacuolation of tunica media with strong positive expression of vascular endothelial growth factor (VEGF) in smooth muscle cells comprising vascular tunica media these alterations were markedly ameliorated in cauliflower then broccoli group. Conclusion: ameliorative effect of cauliflower and broccoli against development of changes in lipid profile and vascular pathology were attributed in partly to lowering the serum level of total lipid, total cholesterol, HDL-C, LDL-C and VLDL-C and decrease the expression of VEGF in smooth muscle cells of blood vessel wall.
    Life Science Journal 12/2013; 10(4):2496-2509. DOI:10.7537/j.2014 · 0.17 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Significance: Mitochondrial function and specifically its implication in cellular redox/oxidative balance is fundamental in controlling the life and death of cells, and has been implicated in a wide range of human pathologies. In this context, mitochondrial therapeutics particularly involving mitochondria-targeted antioxidants have attracted increasing interest as potentially effective therapies for several human diseases. Recent advances: Over the last 10 years, great progress has been made in the development and functional testing of molecules that specifically target mitochondria, and there has been special focus on compounds with antioxidant properties. In this review, we will discuss several such strategies, including molecules conjugated with lipophilic cations (eg. TPP+) or rhodamine, conjugates of plant alkaloids, amino-acid- and peptide-based compounds and liposomes. Critical issue: This area has several major challenges that need to be confronted. Apart from antioxidants and other redox active molecules, current research aims to develop compounds capable of modulating other mitochondria-controlled processes, such as apoptosis and autophagy. Future directions: Multiple chemically different molecular strategies have been developed as delivery tools that offer broad opportunities for mitochondrial manipulation. Additional studies, and particularly in vivo approaches under physiologically relevant conditions, are necessary to confirm the clinical usefulness of these molecules.
    Antioxidants and Redox Signaling 12/2014; 22(8). DOI:10.1089/ars.2014.5952 · 7.67 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Various extrinsic stresses, including hypoxia and oxidative stress, trigger the progression of diseases associated with inflammation and fibrosis via the pathogenic alteration of these stress signals. They include the HIF pathway, induced by hypoxia, and the Nrf2 pathway, induced by oxidative stress. Recent evidence emphasizes that the extrinsic stress-induced phenotypic changes are widely associated with endoplasmic reticulum (ER) stress and induction of the ER stress signal, unfolded protein response. This issue focuses on the recent insights demonstrating the link between molecular mechanisms leading to fibrosis and stress signals. In particular, we summarized the contribution of hypoxia, oxidative stress, and ER stress signals, all of which are common pathogenic pathways for the progression of chronic renal disease, to fibrotic changes, as well as the future aspects of therapeutic approaches targeting these stress pathways to fibrosis in various organs.
    12/2013; 1(4):283-289. DOI:10.1007/s40139-013-0029-4